252 related articles for article (PubMed ID: 24573676)
61. DNA topoisomerase I domain interactions impact enzyme activity and sensitivity to camptothecin.
Wright CM; van der Merwe M; DeBrot AH; Bjornsti MA
J Biol Chem; 2015 May; 290(19):12068-78. PubMed ID: 25795777
[TBL] [Abstract][Full Text] [Related]
62. Human Tim/Timeless-interacting protein, Tipin, is required for efficient progression of S phase and DNA replication checkpoint.
Yoshizawa-Sugata N; Masai H
J Biol Chem; 2007 Jan; 282(4):2729-40. PubMed ID: 17102137
[TBL] [Abstract][Full Text] [Related]
63. Tipin is required for stalled replication forks to resume DNA replication after removal of aphidicolin in Xenopus egg extracts.
Errico A; Costanzo V; Hunt T
Proc Natl Acad Sci U S A; 2007 Sep; 104(38):14929-34. PubMed ID: 17846426
[TBL] [Abstract][Full Text] [Related]
64. AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination.
Kobayashi M; Aida M; Nagaoka H; Begum NA; Kitawaki Y; Nakata M; Stanlie A; Doi T; Kato L; Okazaki IM; Shinkura R; Muramatsu M; Kinoshita K; Honjo T
Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22375-80. PubMed ID: 20018730
[TBL] [Abstract][Full Text] [Related]
65. A novel DNA topoisomerase I inhibitor with different mechanism from camptothecin induces G2/M phase cell cycle arrest to K562 cells.
Wu N; Wu XW; Agama K; Pommier Y; Du J; Li D; Gu LQ; Huang ZS; An LK
Biochemistry; 2010 Nov; 49(47):10131-6. PubMed ID: 21033700
[TBL] [Abstract][Full Text] [Related]
66. Domain interactions affecting human DNA topoisomerase I catalysis and camptothecin sensitivity.
Fiorani P; Amatruda JF; Silvestri A; Butler RH; Bjornsti MA; Benedetti P
Mol Pharmacol; 1999 Dec; 56(6):1105-15. PubMed ID: 10570037
[TBL] [Abstract][Full Text] [Related]
67. Yeast Tdp1 and Rad1-Rad10 function as redundant pathways for repairing Top1 replicative damage.
Vance JR; Wilson TE
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13669-74. PubMed ID: 12368472
[TBL] [Abstract][Full Text] [Related]
68. The distinctive cellular responses to DNA strand breaks caused by a DNA topoisomerase I poison in conjunction with DNA replication and RNA transcription.
Sakasai R; Iwabuchi K
Genes Genet Syst; 2016; 90(4):187-94. PubMed ID: 26616758
[TBL] [Abstract][Full Text] [Related]
69. WRN helicase regulates the ATR-CHK1-induced S-phase checkpoint pathway in response to topoisomerase-I-DNA covalent complexes.
Patro BS; Frøhlich R; Bohr VA; Stevnsner T
J Cell Sci; 2011 Dec; 124(Pt 23):3967-79. PubMed ID: 22159421
[TBL] [Abstract][Full Text] [Related]
70. Camptothecin resistance is determined by the regulation of topoisomerase I degradation mediated by ubiquitin proteasome pathway.
Ando K; Shah AK; Sachdev V; Kleinstiver BP; Taylor-Parker J; Welch MM; Hu Y; Salgia R; White FM; Parvin JD; Ozonoff A; Rameh LE; Joung JK; Bharti AK
Oncotarget; 2017 Jul; 8(27):43733-43751. PubMed ID: 28415827
[TBL] [Abstract][Full Text] [Related]
71. Neutral Porphyrin Derivative Exerts Anticancer Activity by Targeting Cellular Topoisomerase I (Top1) and Promotes Apoptotic Cell Death without Stabilizing Top1-DNA Cleavage Complexes.
Das SK; Ghosh A; Paul Chowdhuri S; Halder N; Rehman I; Sengupta S; Sahoo KC; Rath H; Das BB
J Med Chem; 2018 Feb; 61(3):804-817. PubMed ID: 29290109
[TBL] [Abstract][Full Text] [Related]
72. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin.
Hsiang YH; Lihou MG; Liu LF
Cancer Res; 1989 Sep; 49(18):5077-82. PubMed ID: 2548710
[TBL] [Abstract][Full Text] [Related]
73. Down-regulation of DNA replication in extracts of camptothecin-treated cells: activation of an S-phase checkpoint?
Wang Y; Perrault AR; Iliakis G
Cancer Res; 1997 May; 57(9):1654-9. PubMed ID: 9135002
[TBL] [Abstract][Full Text] [Related]
74. The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants.
Inoue N; Terabayashi T; Takiguchi-Kawashima Y; Fujinami D; Matsuoka S; Kawano M; Tanaka K; Tsumura H; Ishizaki T; Narahara H; Kohda D; Nishida Y; Hanada K
Sci Rep; 2021 Apr; 11(1):7718. PubMed ID: 33833336
[TBL] [Abstract][Full Text] [Related]
75. Tdp1 processes chromate-induced single-strand DNA breaks that collapse replication forks.
Ganguly A; Guo L; Sun L; Suo F; Du LL; Russell P
PLoS Genet; 2018 Aug; 14(8):e1007595. PubMed ID: 30148840
[TBL] [Abstract][Full Text] [Related]
76. Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Fan Y; Weinstein JN; Kohn KW; Shi LM; Pommier Y
J Med Chem; 1998 Jun; 41(13):2216-26. PubMed ID: 9632354
[TBL] [Abstract][Full Text] [Related]
77. Abortive activity of Topoisomerase I: a challenge for genome integrity?
Jakobsen KP; Andersen AH; Bjergbæk L
Curr Genet; 2019 Oct; 65(5):1141-1144. PubMed ID: 31049660
[TBL] [Abstract][Full Text] [Related]
78. Enhanced CPT sensitivity of yeast cells and selective relaxation of Ga14 motif-containing DNA by novel Gal4-topoisomerase I fusion proteins.
Alessandri M; Beretta GL; Ferretti E; Mancia A; Khobta A; Capranico G
J Mol Biol; 2004 Mar; 337(2):295-305. PubMed ID: 15003448
[TBL] [Abstract][Full Text] [Related]
79. Tel1/ATM prevents degradation of replication forks that reverse after topoisomerase poisoning.
Menin L; Ursich S; Trovesi C; Zellweger R; Lopes M; Longhese MP; Clerici M
EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29739811
[TBL] [Abstract][Full Text] [Related]
80. Preferential potentiation of topoisomerase I poison cytotoxicity by PARP inhibition in S phase.
Znojek P; Willmore E; Curtin NJ
Br J Cancer; 2014 Sep; 111(7):1319-26. PubMed ID: 25003660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
